BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2252105)

  • 1. Nucleolar organizer regions (NOR) in hyperplastic and neoplastic prostate disease.
    Deschênes J; Weidner N
    Am J Surg Pathol; 1990 Dec; 14(12):1148-55. PubMed ID: 2252105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar organizer regions in benign and malignant prostatic disease.
    Lloyd SN; Johnson CP; Brown IL; Kirk D
    Histopathology; 1991 May; 18(5):449-52. PubMed ID: 1715842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleolar organiser regions in hyperplastic and neoplastic prostatic tissue.
    Hansen AB; Ostergård B
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(1):9-13. PubMed ID: 1694333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silver-binding nucleolar organizer regions in benign and malignant prostatic lesions.
    Pavlakis K; Alivizatos G; Mitropoulos D; Constantinides C; Skopelitou A; Kittas C; Dimopoulos C
    Urol Int; 1992; 49(3):137-40. PubMed ID: 1281586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
    Helpap B; Riede C
    Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silver staining of nucleolar organizer regions in prostatic lesions.
    Ghazizadeh M; Sasaki Y; Oguro T; Aihara K
    Histopathology; 1991 Oct; 19(4):369-72. PubMed ID: 1718838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AgNOR staining in benign hyperplasia and carcinoma of the prostate.
    Mamaeva S; Lundgren R; Elfving P; Limon J; Mandahl N; Mamaev N; Henrikson H; Heim S; Mitelman F
    Prostate; 1991; 18(2):155-62. PubMed ID: 1706512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silver-stained nucleolar organizer regions in the differentiation of prostatic hyperplasia, intraepithelial neoplasia, and adenocarcinoma.
    Cheville JC; Clamon GH; Robinson RA
    Mod Pathol; 1990 Sep; 3(5):596-8. PubMed ID: 1700418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
    Chiusa L; Galliano D; Formiconi A; Di Primio O; Pich A
    Cancer; 1997 May; 79(10):1956-63. PubMed ID: 9149023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argyrophilic nucleolar organizer regions in atypical adenomatous hyperplasias, prostatic intraepithelial neoplasias and prostatic neoplasms.
    Mukherjee J; Misra V; Gupta SC; Gupta AK; Tandon SP
    Urol Int; 1997; 58(2):75-9. PubMed ID: 9096266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereological estimation of nucleolar organizer regions in prostatic tissue with an optical disector.
    Hansen AB; Andersen CB
    APMIS; 1992 Feb; 100(2):135-41. PubMed ID: 1554487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar organizer regions as discriminators for the diagnosis of well-differentiated adenocarcinoma of the prostate.
    Schned AR
    Arch Pathol Lab Med; 1993 Oct; 117(10):1000-4. PubMed ID: 8215819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between the nucleolar organizer region in adenocarcinoma of the prostate and the Gleason system].
    Sentinelli S; Pizzuti V; Rondanelli E; Viggiani F; Paolini R
    Pathologica; 1992; 84(1089):49-55. PubMed ID: 1379709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [AGNOR analyses of prostate carcinomas of high and malignancy].
    Helpap B; Riede C
    Verh Dtsch Ges Pathol; 1993; 77():93-7. PubMed ID: 7511310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolar organizer regions and PCNA expression in prostatic cancers.
    Kawase N; Shiokawa A; Ota H; Saitoh T; Yoshida H; Kazama K
    Pathol Int; 1994 Mar; 44(3):213-22. PubMed ID: 7517763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive activity in latent prostate carcinoma defined by argyrophilic staining of the nucleolar organizer regions (AgNOR).
    Konishi N; Nakaoka S; Tsuzuki T; Kitahori Y; Nishii K; Kitamura M; Ohshima M; Hiasa Y
    Pathol Int; 1994 Apr; 44(4):297-302. PubMed ID: 7519105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar organizer regions in low- and high-grade carcinomas of the prostate.
    Helpap B; Riede C
    World J Urol; 1995; 13(3):195-9. PubMed ID: 7550395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF.
    Sakr WA; Sarkar FH; Sreepathi P; Drozdowicz S; Crissman JD
    Prostate; 1993; 22(2):147-54. PubMed ID: 7681206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silver staining nucleolar organizer region in prostate cytology.
    Bittinger A; von Keitz A; Rüschoff J; Melekos MD
    Zentralbl Pathol; 1994 Mar; 140(1):103-6. PubMed ID: 7515666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.